跳至主要内容
临床试验/NCT04607070
NCT04607070已完成不适用

Ischemic Strokes While on NOAC - How Compliance Matters

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
1
主要终点
Compliance affects the outcomes of ischemic stroke during NOAC usage.

研究概览

简要总结

This study is aimed to depict the epidemiological trend, aetiologies, clinical characteristics, treatment options of IS-NOAC in face of the rapidly increasing NOAC usage. Knowledge on this ischaemic stroke entity will define clinical characteristics, identify preventable causes and inform resource allocation on the evaluation modalities, reperfusion strategies and forecast future burden of IS-NOAC.

详细描述

Data will be retrieved from the stroke registry of Prince of Wales Hospital which recorded all in- and out-patients with stroke or transient ischaemic attack (TIA). All consecutive adult patients with known AF who developed ischaemic stroke or TIA in 2010, 2012, 2014, 2016 and 2018 (i.e. 5 full yearly time-points) and categorize the patients according to their anticoagulation status (elaborated below) with the inclusion and exclusion criteria stated will be recruited.

All demographic data, blood results, imaging and assessment data will be retrieved from electronic patient record (CMS system) and stroke registry. All-cause mortality at 1 year will be verified via CMS system too.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who were ethnic Chinese
  • Patients with known AF
  • Patient who suffered from ischaemic stroke

排除标准

  • Patient who are non-ethnic Chinese
  • Patient who suffered from haemorrhagic stroke

研究组 & 干预措施

Stroke patient

This is a registry-based study that will involve consecutive adult patients with known AF who developed ischaemic stroke or TIA in years 2010, 2012, 2014, 2016 and 2018.

结局指标

主要结局

Compliance affects the outcomes of ischemic stroke during NOAC usage.

时间窗: 30 Sept 2021

To depict epidemiological trend and aetiologies on different dosage of NOAC in stroke patients.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. IP Yiu Ming Bonaventure

Specialist resident

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验